Viking Therapeutics, Inc.
Biopharma developing novel therapies for metabolic and endocrine disorders like obesity and NASH.
VKTX | US
Overview
Corporate Details
- ISIN(s):
- US92686J1060
- LEI:
- Country:
- United States of America
- Address:
- 9920 PACIFIC HEIGHTS BLVD, SUITE 350, 92121 SAN DIEGO
- Website:
- https://vikingtherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. The company's clinical pipeline includes drug candidates designed to treat prevalent conditions such as obesity and non-alcoholic steatohepatitis (NASH). Its lead programs aim to address significant unmet medical needs by targeting the underlying pathophysiology of these diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Viking Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Viking Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Viking Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
